- 专利标题： PHARMACEUTICAL COMPOSITION
-
申请号： US17645509申请日： 2021-12-22
-
公开(公告)号： US20220110934A1公开(公告)日： 2022-04-14
- 发明人: Takashi SATO , Takeshi Shimosato , Tatsuru Moritani , Tadahiko Morinaga , Yuichi Sato , Akihiro Kotsugai
- 申请人： Takashi SATO , Takeshi Shimosato , Tatsuru Moritani , Tadahiko Morinaga , Yuichi Sato , Akihiro Kotsugai
- 申请人地址： JP Nagano; JP Nagano; JP Kanagawa; JP Kanagawa; JP Kanagawa; JP Shizuoka
- 专利权人： Takashi SATO,Takeshi Shimosato,Tatsuru Moritani,Tadahiko Morinaga,Yuichi Sato,Akihiro Kotsugai
- 当前专利权人： Takashi SATO,Takeshi Shimosato,Tatsuru Moritani,Tadahiko Morinaga,Yuichi Sato,Akihiro Kotsugai
- 当前专利权人地址： JP Nagano; JP Nagano; JP Kanagawa; JP Kanagawa; JP Kanagawa; JP Shizuoka
- 优先权： JP2019-118289 20190626
- 主分类号： A61K31/496
- IPC分类号： A61K31/496 ; A61K9/16
摘要：
A pharmaceutical composition including particles each containing a water-soluble base material and a poorly water-soluble compound, the water-soluble base material containing a rapidly water-soluble compound, wherein the poorly water-soluble compound is a kinase inhibitor and exists in an amorphous state in the water-soluble base material.
信息查询
IPC分类:
